2022
DOI: 10.1080/08880018.2021.2002485
|View full text |Cite
|
Sign up to set email alerts
|

Outcome and prognostic factors in childhood B non-Hodgkin lymphoma from India: Report by the Indian Pediatric Oncology Group (InPOG-NHL-16-01 study)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 46 publications
0
9
0
Order By: Relevance
“…LDH is an enzyme existing in multiple cell types and serum levels rise in acute phase reactions as well as following lysis or necrosis not only of blood cells but of any cell in the body, therefore multiple reasons for LDH increases exist in patients after operative procedures or during critical illness. [11][12][13] Our cost analysis showed a relevant cost e ciency of HI over fHb in ICU patients on ECLS 4.347.25 (794.21-5350.46) USD per ECLS patient due to a median number of 104 measurements performed per patient. Thus, in a ctional 10 bed ICU with 2 patients being on ECLS (4 daily measurements) and 8 patients without ECLS support (1 daily measurements), preferring HI over fHb would save 20.064.24 USD per month and preferring HI over LDH measurements would save 1.769.04 USD per month.…”
Section: Discussionmentioning
confidence: 86%
See 2 more Smart Citations
“…LDH is an enzyme existing in multiple cell types and serum levels rise in acute phase reactions as well as following lysis or necrosis not only of blood cells but of any cell in the body, therefore multiple reasons for LDH increases exist in patients after operative procedures or during critical illness. [11][12][13] Our cost analysis showed a relevant cost e ciency of HI over fHb in ICU patients on ECLS 4.347.25 (794.21-5350.46) USD per ECLS patient due to a median number of 104 measurements performed per patient. Thus, in a ctional 10 bed ICU with 2 patients being on ECLS (4 daily measurements) and 8 patients without ECLS support (1 daily measurements), preferring HI over fHb would save 20.064.24 USD per month and preferring HI over LDH measurements would save 1.769.04 USD per month.…”
Section: Discussionmentioning
confidence: 86%
“…15 Unlike fHb and LDH, HI is not routinely displayed as a lab result since it is considered an internal parameter evaluating the preanalytical condition of blood samples but can be made readily available for clinicians free of charge. [11][12][13] Previous investigations show good correlation of several quantitative and qualitative measurements of various analytical devices measuring HI to fHb concentrations in healthy volunteers or arti cial plasma. 14,16,17 Bosma et.…”
Section: Introductionmentioning
confidence: 92%
See 1 more Smart Citation
“… 4 , 14 Owing to various reasons, some trial groups mainly conducted retrospective studies to review the outcome of standard treatment or report on specific issues related to a treatment protocol, such as complications or late effects. 19 , 25 , 38 Recognizing challenges in accessing care, INPHOG has a subcommittee focused on multicenter research in access to care and is enrolling patients in extensive multicenter studies that are examining out-of-pocket expenditure, pathways to diagnosis, and the effects of COVID-19 on treatment access. The reasons leading to the slow development of clinical trial groups are multifactorial, and some are due to local regulatory issues.…”
Section: Discussionmentioning
confidence: 99%
“…PFH levels serve as a valuable tool for the early detection of subclinical thrombosis [5] and pump thrombosis in patients under ECMO or mechanical circulatory support with VAD [5][6][7][8]. Additionally, plasma LDH levels are used to aid in the identification of hemolysis [9][10][11]. It is important to note that the measurements of both laboratory parameters come at a considerable cost, and the reliability of plasma LDH levels may be compromised in patients with hyperbilirubinemia, a condition often observed in patients undergoing mechanical circulatory support.…”
Section: Introductionmentioning
confidence: 99%